Performance of rotavirus vaccines in developed and developing countries
Clicks: 269
ID: 118827
2010
The World Health Organization estimates that rotavirus diarrhea results in approximately half a million deaths and approximately 2.4 million hospitalizations in developing countries each year. Two live oral rotavirus vaccines, RotaTeq® (RV 5; Merck) and Rotarix® (RV 1; GlaxoSmithKline) with good eff …
| Reference Key |
v2010humanperformance
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jiang V;Jiang B;Tate J;Parashar UD;Patel MM;; |
| Journal | human vaccines |
| Year | 2010 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Incidence
Diarrhea / epidemiology
diarrhea / prevention & control
gastroenteritis / prevention & control
rotavirus infections / prevention & control*
rotavirus vaccines / immunology*
gastroenteritis / epidemiology
rotavirus infections / epidemiology*
rotavirus vaccines / administration & dosage*
developing countries
manish m patel
developed countries
pmid:20622508
pmc3322519
doi:10.4161/hv.6.7.11278
victoria jiang
baoming jiang
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.